Qatar-based startup iQtech LLC, a pioneer in advanced medical simulation, has successfully closed its first investment round, marking a significant milestone in its corporate journey. The funding, secured from European assessment leader Selexi and deep-tech firm Yuniro, will accelerate the development of its innovative training technologies. This strategic investment transitions the company from a promising concept into a structured, financially-backed entity poised for regional expansion.
Strategic Investment for Medical Innovation
The investment round was led by Selexi, a prominent European provider of computer-based testing solutions, alongside deep-tech collaborator Yuniro. Their participation provides not only essential capital but also a wealth of technical expertise in assessment systems, automation, and digital infrastructure. This strategic partnership is set to significantly enhance iQtech’s technological capabilities and market position.
This new capital is primarily allocated to advancing EsculapioVR, iQtech's flagship AI-powered medical training and assessment platform. The system is designed to revolutionize professional education by blending immersive simulations with intelligent, data-driven evaluations. The funding will fast-track its development cycle and prepare the platform for a broader market launch across the region.
Revolutionizing Training with EsculapioVR
EsculapioVR integrates immersive virtual reality (VR) with sophisticated artificial intelligence to create highly realistic clinical scenarios for trainees. Medical professionals can practice complex procedures in a controlled, risk-free environment while receiving objective feedback on their performance. This innovative approach aims to bridge the critical gap between theoretical knowledge and practical, hands-on application.
By leveraging cross-reality (XR) technologies, the platform offers a new paradigm for medical education and competency assessment. It measures key metrics such as decision-making accuracy, procedural efficiency, and skill development in real time. This provides a more objective and comprehensive evaluation framework compared to traditional training methods, ensuring higher standards of care.
While its primary focus is on healthcare, iQtech’s high-fidelity simulation platforms are also designed for the civil and military sectors. The underlying technology addresses critical training needs where realistic operational simulations are essential for mission success. This versatility positions the company for sustainable growth across multiple high-stakes industries requiring specialized training.
Fostering Growth in the Qatari Ecosystem
Operating from its base in Doha, iQtech credits much of its success to the supportive ecosystem of the Qatar Science & Technology Park (QSTP). The company highlighted the incubator’s guidance, mentorship, and infrastructure as instrumental in achieving this funding milestone. This achievement underscores the vital role of local innovation hubs in nurturing and scaling emerging technology startups.
With this new financial backing, iQtech plans to strengthen its core technology infrastructure and strategically expand its operational footprint. The company is targeting growth opportunities across Qatar and the broader Middle East and North Africa (MENA) region. This expansion will make its advanced training solutions accessible to a wider professional audience seeking cutting-edge educational tools.
This successful funding round marks a pivotal transition for iQtech, elevating it from a bold vision to a structured and well-resourced enterprise. Supported by its new partners and the robust QSTP ecosystem, the company is strongly positioned to become a leader in XR-enhanced training. iQtech’s journey is just beginning as it prepares to set new industry standards in medical simulation technology.